Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies

Biologicals

Volumn 40, Issue 6, 2012, Pages 399-404

  Simões, Marisol ^a   Camacho, Luiz Antonio B ^a   Yamamura, Anna M Y ^a   Miranda, Emily Hime ^a   Cajaraville, Ana Carolina R A ^a   da Silva Freire, Marcos ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Accuracy; Neutralizing antibody; PRNT; Reliability; Yellow fever

Indexed keywords

NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; YELLOW FEVER FLAVIVIRUS ANTIBODY; YELLOW FEVER VACCINE;

ADULT; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLASSIFICATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; HUMAN; MALE; METHODOLOGY; NONHUMAN; PLAQUE REDUCTION NEUTRALIZATION TEST; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; YELLOW FEVER FLAVIVIRUS;

ANTIBODIES, VIRAL; HUMANS; LIMIT OF DETECTION; NEUTRALIZATION TESTS; REPRODUCIBILITY OF RESULTS; VIRAL PLAQUE ASSAY; YELLOW FEVER VIRUS;

FLAVIVIRUS; YELLOW FEVER VIRUS;

EID: 84868351862     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2012.09.005     Document Type: Article

References (25)

1. Monath T.P. Yellow fever: an update. Lancet Infect Dis 2001, 1(1):11-20.
2. Tomori O. Yellow fever: the recurring plague. Crit Rev Clin Lab Sci 2004, 41(4):391-427.
3. World Health Organization [Accessed 01.17.2010]. http://www.who.int/mediacentre/factsheets/fs100/en/.
4. Camacho L.A., Freire M.S., Leal M.L.F., Aguiar S.G., Nascimento J.P., Iguchi T., Collaborative Group for the Study of Yellow Fever Vaccines, et al. Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial. Rev Saude Publica 2004, 38(5):671-678.
5. Monath T.P. Yellow fever vaccine. Vaccines 2004, 1095-1176. Elsevier, Phildelphia. 4th ed. S. Plotkin, W.A. Orenstein (Eds.).
6. Secretaria de Vigilância em Saúde Guia de vigilância epidemiológica - Febre amarela. Normas e Manuais Técnicos 2005, http://portal.saude.gov.br/portal/arquivos/pdf/febre_amarela_gve.pdf.
7. Santos N.O.S., Benati F.J. Diagnóstico laboratorial das viroses. Introdução à virologia humana 2008, 83-116. Guanabara Koogan S.A, Rio de Janeiro. 2nd ed. N.S.O. Santos, M.T.V. Romanos, M.D. Wigg (Eds.).
8. De Madrid A.T., Porterfield J.S. A simple micro-culture method for the study of group B arboviruses. Bull World Health Organ 1969, 40(1):113-121.
9. Niedrig M., Lademann M., Emmerich P., Lafrenz M. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, hemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999, 4(12):867-871.
10. Roehrig J.T., Hombach J., Barrett A.D. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol 2008, 21(2):123-132.
11. Galler R., Pugachev K.V., Santos C.L., Ocran S.W., Jabor A.V., Rodrigues S.G., et al. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 2001, 290(2):309-319.
12. Marchevsky R.S., Freire M.S., Coutinho E.S., Galler R. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology 2003, 316(1):55-63.
13. Freire M.S., Mann G.F., Marchevsky R.S., Yamamura A.M., Almeida L.F., Jabor A.V., et al. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Vaccine 2005, 23(19):2501-2512.
14. Marchevsky R.S., Leal M.L., Homma A., Coutinho E.S., Coutinho E.S., Camacho L.A., et al. Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos. Biologicals 2006, 34(3):191-197.
15. Camacho L.A.B., Freire M.S., Leal M.L.F., Maia M.L.S., Martins R.M., Collaborative Group for Studies with Yellow Fever Vaccine Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Vaccine 2007, 25(16):3118-3123.
16. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1(1):6.
17. Stefano I., Sato H.K., Pannuti C.S., Omoto T.M., Mann G., Freire M.S., et al. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine. Vaccine 1999, 17(9-10):1042-1046.
18. Mcgraw K.O., Wong S.P. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996, 1(1):30-46.
19. Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000, 45:23-41.
20. Szklo M., Nieto F.J. Quality assurance and control. Epidemiology: beyond the basics 2000, 343-404. Aspen Publishers, Maryland. M. Szklo, F.J. Nieto (Eds.).
21. Johnson B.W., Kosoy O., Martin D.A., Noga A.J., Russell B.J., Johnson A.A., et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 2005, 5(2):137-145.
22. Santaella J., McLean R., Hall J.S., Gill J.S., Bowen R.A., Hadow H.H., et al. West Nile virus serosurveillance in Iowa white-tailed deer (1999-2003). Am J Trop Med Hyg 2005, 73(6):1038-1042.
23. Dobler G., Wölfel R., Schmüser H., Essbauer S., Pfeffer M. Seroprevalence of tick-borne and mosquito-borne arboviruses in European brown hares in Northern and Western Germany. Int J Med Microbiol 2006, 296:80-83.
24. Sondgeroth K., Blitvich B., Blair C., Terwee J., Junge R., Sauther M., et al. Assessing flavivirus, lentivirus, and herpesvirus exposure in free-ranging ring-tailed lemurs in southwestern Madagascar. J Wildl Dis 2007, 43(1):40-47.
25. Cohen B.J., Audet S., Andrews N., Beeler J., WHO Working Group on Measles Plaque Reduction Neutralization Test Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 2007, 26(1):59-66.